QN
Quoin Pharmaceuticals, Ltd.
QNRX · NASDAQ
$6.90 -0.29% (-$0.02)
1M +30.26%
Market Cap $13.9M
P/E Ratio -
Div. Yield -
ROE 304.87%
Bulios Fair Price
$9.3
34.8% upside
Trenutna cena
$6.9
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica QNRX trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
1/9Valuation
58 /100
Fair P/B 3.52x
P/E N/A
EV/EBITDA N/A
Growth
100 /100
Growing Book val. growth 20.99%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
0 /100
Poor ROIC 359.18%
ROE 304.87%
ROA 156.71%
Debt
96 /100
Low Debt/Equity 0.00x
Current ratio 1.76x
Int. coverage N/A
Stability
8 /100
Unstable Beta 1.66x
EPS volatility 837.92%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o QNRX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Michael Myers
Employees
4
Headquarters
Ashburn
Prihajajoči dogodki
05 NOV.
Earnings
Upcoming earnings report